Racial differences in renal kallikrein excretion: Effect of the ovulatory cycle

Kidney International

Volumn 54, Issue 5, 1998, Pages 1652-1658

  Kailasam, Mala T ^b   Martinez, Joseph A ^b   Cervenka, Justine H ^b   Yen, Samuel S C ^b   O'Connor, Daniel T ^b   Parmer, Robert J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Gender; Genetics; Hypertension; Kallikrein; Ovulatory cycle; Race

Indexed keywords

KALLIKREIN;

ADULT; ARTICLE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; KIDNEY METABOLISM; MENSTRUAL CYCLE; NEGRO; NORMAL HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 0031727641     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00147.x     Document Type: Article

References (52)

1. SCICLI AG, CARRETERO OA: Renal kallikrein-kinin system. Kidney Int 29:120-130, 1986
2. LEVINSKY NG: The renal kallikrein-kinin system. Circ Res 44:441-451, 1979
3. ZINNER SH, MARGOLIUS HS, ROSNER B, KEISER HR, KASS EH: Familial aggregation of urinary kallikrein concentration in childhood: Relation to blood pressure, race and urinary electrolytes. Am J Epidemiol 104:124-132, 1976
4. MARGOLIUS HS, GELLER R, PISANO JJ, SJOERDSMA A: Altered urinary kallikrein excretion in human hypertension. Lancet 2:1062-1065, 1971
5. GELLER RG, MARGOLIUS HS, PISANO JJ, KEISER HR: Urinary kallikrein excretion in spontaneously hypertensive rats. Circ Res 36(Suppl 1):103-106, 1975
6. MARTINEZ JA, DAO TT, KAILASAM MT, PARMER RJ, O'CONNOR DT: Renal kallikrein excretion: Early changes in subjects at genetic risk for essential hypertension. J Invest Med 43(Suppl 1):166A, 1995
7. BERRY TD, HASSTEDT SJ, HUNT SC, WU LL, SMITH JB, ASH KO, KUIDA H, WILLLIAMS RR: A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 13:3-8, 1989
8. PRAVENEC M, KREN V, KUNES J, SCILI AG, CARRETERO OA, SIMONET L, KURTZ, TW: Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension 17:242-246, 1991
9. FERRI C, BELLINI C, CARLOMAGNO A, PERRONE A, SANTUCCI A: Urinary kallikrein and salt sensitivity in essential hypertensive males. Kidney International 46:780-788, 1994
10. BONNER G, THIEVEN B, RUTTEN H, CHROSCH R, KRONE W: Renal kallikrein is a determinant of salt sensitivity. J Hypertension 11(Suppl 5):S210-S211, 1993
11. BLACKWOOD AM, INOUE J, SAGNELLA GA, MILLER MA, MARKANDU ND, MACGREGOR GA: Are the changes in urinary kallikrein excretion on altering sodium intake an index of salt sensitivity? J Human Hypertens 8:619-621, 1994
12. WARREN SE, O'CONNOR DT: Does a renal vasodilator system mediate racial differences in essential hypertension? Am J Med 69:425-429, 1980
13. HUGHES GS, MARGOLIUS HS, PETERS R, OEXMANN MJ, CHAO J, LINDENMAYRT G: Gender differences of human tissue kallikrein and an erythrocyte kallikrein like enzyme in essential hypertension. J Lab Clin Med 112:612-618, 1988
14. ALBANO JDM, CAMPBELL SK, FARRER A, MILLAR JGB: Gender differences in urinary kallikrein excretion in man: Variation throughout the menstrual cycle. Clin Sci 86:227-231, 1994
15. PARMER RJ, KAILASAM MT, MARTINEZ, JA, WRIGHT, FA, WILSON AF, O'CONNOR DT: Evidence suggesting that urinary kallikrein excretion is heritable in African-American families with essential hypertension. (abstract) Hypertension 26:545, 1995
16. AMUNDSEN E, PUTTER J, FRIBERGER P, KNOS M, LARSTRATEN M, CLEASON G: Methods for determination of glandular kallikrein by means of a chromogenic tri-peptide substrate. Adv Exp Med Biol 120 A:83-94, 1979, in Kinins II. Biochemistry, Pathophyology, and Clinical Aspects. edited by FUJII S, MORIYA H, SUZIKI T, New York, Plenum Press, 1997
17. LASLFY BL, WANG CF, YEN SSC: The effects of estrogen and progesterone on the functional capacity of the gonadotrophs. J Clin Endocrinol Metab 41:820-826, 1975
18. COCKCROFI DW, GAULT MH: Prediction of creatinine clearance from serum creatininc. Nephron 16:31-41, 1976
19. WILKINSON L: SYSTAT: The System for Statistics. Evanston, SYSTAT, Inc., 1988
20. KAPLAN NM: Hypertension in the population at large (chapt 1), in Clinical Hypertension, edited by KAPLAN NM, Baltimore, Williams and Wilkins, 1990, pp 1-25
21. KAPLAN NM: Primary hypertension: Pathogenesis (chapt 3), in Clinical Hypertension, edited In KAPLAN NM, Baltimore, Williams and Wilkins, 1990, pp 54-111
22. LACROIN AZ: Gender effects and hypertension in women, in Hypertension Primer: The Essentials of High Blood Pressure (chapt C2), edited by IZZO JL JR, BLACK HR, Council on High Blood Pressure Research, American Heart Association, 1993, pp 150-153
23. PARMFR RJ, CFRVENKA JH, STONF RA, O'ONNOR DT: Autonomic function in hypertension. Are there racial differences? Circulation 81:1305-1311, 1990
24. PARMER RJ, STONE RA, CERVENKA JH: Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium. Hypertension 24:752-757, 1994
25. CAMPESE VM, PARISE M, KARUBIAN F, BIGAZZI R: Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension 18:805-812, 1991
26. HANES DS, WEIR MR, SOWERS JR: Gender considerations in hypertension pathophysiology and treatment. Am J Med 1041(Suppl 3A): 10S-21S, 1996
27. WEIR MR, HANES DS: Hypertension in African-Americans: A paradigm of metabolic disarray. Semin Nephrol 16:102-109, 1996
28. HOROWITZ D, MARGOLIUS HS, KFISFR HR: Efflects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man. J Clin Endo Metab 47:296-299, 1978
29. LFVY SB, LILLFY JJ, FRIGON RP, STONF RA: Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. J Clin Invest 60:129-138, 1977
30. COLLINS, JA: Diagnostic assessment of the ovulatory process. Semin Reproductive Endocrinol 8:145-155, 1990
31. BEFK EV, HOUBEN JHM, VAN ES PN, WILLEKES C, KORIEN ECC M, DE LEEUW PW, PEETERS LLH: Peripheral hemodynamics and renal function in relation to the menstrual cycle. Clin Sci 91:163-168, 1996
32. MANHEM K, JERN S: Influence of daily-life activation on pulse rate and blood pressure changes during the menstrual cycle. J Human Hypertens 8:851-856, 1994
33. DAVISON JM, NOBLE MCB: Serial changes in 24 hours creatinine clearance during normal menstrual cycles and the first trimester of pregnancy. Br J Obst Gyn 88:10-17, 1981
34. NAFZIGER AN, SCHWARTZMAN MS, BERHNO JS: Absence of tobramycin pharmacokinetic and creatinine clearance variation during the menstrual cycle: Implied absence of variation in glomerular filtration rate. J Clin Pharmacol 29:757-763, 1989
35. ZHOU GX, CHAO L, CHAO J: Kallistatin: A novel human tissue kallikrein inhibitor. J Biol Chem 267:25873-25880, 1993
36. MADEDDU P, OPPESS M, RUBATTU S, TONOLO GC, DESSI-FULGHERI P, GLORIOSO N, RAPPELLI A: Prokallikrein and kallikrein inhibitors in human urine. J Hypertens 3(Suppl 3):S283-S286, 1985
37. HUNT SC, WU LL, SLATTERY ML, MEIKLE AW, WILLAMS RR: Environmental determinants of urinary kallikrein exeretion. Am J Hyppertens 6:226-233, 1993
38. M'BUYAMBA-KABANGU JR, AMERY A, LHNEN P: Differences between black and white persons in blood pressure and related biological variables. J Human Hypertens 8:163-170, 1994
39. SONG Q, CHAO J, CHAO L: DNA polymorphisms in the 5′-flanking region of the human tissue kallikrein gene. Hum Genet 99:727-734, 1997
40. EVANS BA, YUN ZX, CLOSE JA, TRFGFAR GW, KHAMURA N, NAKANISHI S, CALLEN DF, BANKER E, HYLAND VJ, SUTHERLAND GR, RICHARDS RI: Structural and chromosomal localization of the human renal kallikrein gene. Biochemistry 27:3124-3129, 1988
41. RIEGMAN PHJ, VLIFTSTRA RJ, SUURMEIJER L, CLEUTJENS CBJM, TRAPMAN J: Characterization of the human kallikrein locus, Genomics 14:6-11, 1992
42. BEAUBIEN G, ROSENSKI-CHUOIN I, MATTEI MG, MBIKAY M, CHREHEN M, SEIDAH NG: Gene structure and chromosomal localization of plasma kallikrein. Biochemistry 30:1628-1635, 1991
43. O'CONNOR DT: Response of the renal kallikrein-kinin system, intravascular volume, and renal hemodynamics to sodium restriction and diuretic treatment in essential hypertension. Hypertension 4(Supp III):III-72-III-78, 1982
44. VIO CP, LOYOLA S, VELARDF V: Localization of components of the kallikrein-kinin system in the kidney: Relation to renal function. Hypertension 19(Supp II):II-10-II-16, 1992
45. SAITOH S, SCILI AG, PETERRSON E, CARRFTERO OA: Effect of inhibiting renal kallikrein on prostaglandin E2, water, and sodium excretion. Hypertension 25:1008-1013, 1995
46. FALKNFR B, KUSHNFR H, LEVISON S, CANESSA M: Albuminuria in association with insulin and sodium-lithium countertransport in young African Americans with borderline hypertension. Hypertension 25: 1315-1321, 1995
47. FALKNKR B, CANESSA M, LEVISON S, KUSHNER H: Sodium-lithium countertransport is associated with insulin resistance and urinary albumin excretion in young African-Americans. Am J Kidney Dis 29:45-53, 1997
48. FALKNER B, HULMAN S, TANNENBAUM J, KUSHNER H: Insulin resistance and blood pressure in young black men. Hypertension 16:706-711, 1990
49. FALKNER B, HULMAN S, KUSHNER H: Hyperinsulinemia and blood pressure sensitivity to sodium in young blacks. J Am Soc Nephrol 3:940-946, 1992
50. FALKNER B, KUSHNER H, TUEFNKO T, SUMNER AE, MARSH JB: Insulin sensitivity, lipids, and blood pressure in American blacks Arterioscler thromb Vasc Biol 15:1798-1804, 1995
51. FALKNER B, HULMAN S, KUSHNER H: Insulin-stimulated glucose utilization and borderline hypertension in young adult backs. Hypertension 22:18-25, 1993
52. SUMMERSON JH, BELL RA, KONEN JC: Racial differences in the prevalence of microalbuminuria in hypertension. Am J Kidney Dis 26:577-5779, 1995